13F Data
13F filer · CIK 1055951

ORBIMED ADVISORS LLC

New York, NY · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$5.4B
+$351.4M vs prior
Positions
129
New / sold out
42 / 26
Added / reduced
32 / 27
Turnover
20.2%
buys $1.1B · sells $1.4B
Top-10 weight
42.1%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewUNITEDHEALTH GROUP INC+161,100–+$67.0M
NewASCENDIS PHARMA A/S+244,456–+$65.2M
NewHUMANA INC+164,100–+$65.2M
NewODYSSEY THERAPEUTICS INC+3,001,198–+$56.2M
NewARCUTIS BIOTHERAPEUTICS INC+2,042,000–+$53.5M
AddedCOGENT BIOSCIENCES INC+1,359,200+422.0%+$52.6M
NewSPDR SERIES TRUSTPUT+300,000–+$47.5M
AddedASTRAZENECA PLC+245,500+36.6%+$45.9M
AddedSTRUCTURE THERAPEUTICS INC+733,997+49.7%+$39.4M
NewABIVAX SACALL+200,000–+$26.7M
64 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outMDXHEALTH SACALL-124,306,000-100.0%$-285.9M
Sold outAVITA MEDICAL INCCALL-40,966,100-100.0%$-154.4M
Sold outMYRIAD GENETICS INC-125,000,000-100.0%$-122.9M
ReducedENLIVEN THERAPEUTICS INC-1,182,906-14.9%$-60.0M
Sold outPFIZER INC-1,946,500-100.0%$-54.7M
ReducedDISC MEDICINE INC-710,015-66.5%$-51.9M
Sold outDANAHER CORP DEL-265,800-100.0%$-50.4M
ReducedSIONNA THERAPEUTICS INC-974,825-27.6%$-42.9M
Sold outASCENDIS PHARMA A/S-181,977-100.0%$-41.6M
ReducedARGENX SE-44,020-32.2%$-40.8M
43 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $4.7BQ3 2013: $5.6BQ4 2013: $6.8BQ1 2014: $8.1BQ2 2014: $8.5BQ3 2014: $9.6BQ4 2014: $10.5BQ1 2015: $11.7BQ2 2015: $13.6BQ3 2015: $9.9BQ4 2015: $11.0BQ1 2016: $9.5BQ2 2016: $9.6BQ3 2016: $8.8BQ4 2016: $7.8BQ1 2017: $8.8BQ2 2017: $9.5BQ3 2017: $10.5BQ4 2017: $15.7BQ1 2018: $8.1BQ2 2018: $8.4BQ3 2018: $8.3BQ4 2018: $5.4BQ1 2019: $6.5BQ2 2019: $6.5BQ3 2019: $5.3BQ4 2019: $7.0BQ1 2020: $6.0BQ2 2020: $7.1BQ3 2020: $8.0BQ4 2020: $11.4BQ1 2021: $10.7BQ2 2021: $9.9BQ3 2021: $9.1BQ4 2021: $7.8BQ1 2022: $6.2BQ2 2022: $5.5BQ3 2022: $5.4BQ4 2022: $5.9BQ1 2023: $5.1BQ2 2023: $5.5BQ3 2023: $4.7BQ4 2023: $5.0BQ1 2024: $6.1BQ2 2024: $5.8BQ3 2024: $6.6BQ4 2024: $4.9BQ1 2025: $5.3BQ2 2025: $5.1BQ3 2025: $4.3BQ4 2025: $5.7BQ1 2026: $5.0BQ2 2026: $5.4B
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1EDGEWISE THERAPEUTICS INCCOM15,518,492$630.5M11.68%
2ENLIVEN THERAPEUTICS INCCOM6,776,632$343.9M6.37%
3LLYELI LILLY & CO257,900$309.3M5.73%
4MBX BIOSCIENCES INCCOM3,428,736$189.3M3.51%
5SINOVAC BIOTECH LTDSHS2,718,735$184.5M3.42%
6ASTRAZENECA PLCORD915,700$171.1M3.17%
7STRUCTURE THERAPEUTICS INCSPONSORED ADS2,209,400$118.6M2.20%
8SIONNA THERAPEUTICS INCCOM2,555,877$112.4M2.08%
9CORVUS PHARMACEUTICALS INCCOM7,165,006$107.0M1.98%
10ARRIVENT BIOPHARMA INCCOM3,027,328$105.2M1.95%
119 more rows. Subscribe for $29/month to see every row, download the data and use the API.